Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
428
NCT01044836
Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 31, 2010
Completion: Aug 31, 2010
NCT01270997
Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients
Phase: Phase 3
Start: Dec 31, 2010
Completion: May 31, 2012
NCT01431404
Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects
Start: Aug 31, 2011
Completion: Jun 30, 2013
NCT01894412
Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers
Start: Jul 31, 2013
Completion: Dec 31, 2015